Combating MDSCs and chronic inflammation, while monitoring MDSCs and CD247 in T-cells and NK cells, may provide valuable tools for choosing the correct therapeutic regiments and timing while taking into account both the cancer and immune factors. This evidence concerns the gene CD247 and cancer.